Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lactose (1 trial)
ornithine aspartate (1 trial)
lactobacillus reuteri (1 trial)
Brain Diseases (Phase 4)
Hepatic Encephalopathy (Phase 4)
Trials (2 total)
Trial APIs (3 total)